Global Health has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 14, 2024, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024. Further, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code for prevention of Insider Trading, the Trading Window of the Company is already closed from October 1, 2024 and will re-open after 48 hours from the declaration of above said results.
The above information is a part of company’s filings submitted to BSE.
